Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003992

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 76,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2022-04-07 Grant or award · Share Option +65,420 65,420 D
Tessari Eben CHIEF OPERATING OFFICER 2022-04-07 Grant or award · Restricted Share Unit +10,905 10,905 D
Loading xslF345X03/form4-04112022_010412.xml…